WO2024089260 - LACTIPLANTIBACILLUS PLANTARUM FOR USE IN ADDRESSING THE SYMPTOMS OF IRRITABLE BOWEL SYNDROME
National phase entry:
Publication Number
WO/2024/089260
Publication Date
02.05.2024
International Application No.
PCT/EP2023/080102
International Filing Date
27.10.2023
Title **
[English]
LACTIPLANTIBACILLUS PLANTARUM FOR USE IN ADDRESSING THE SYMPTOMS OF IRRITABLE BOWEL SYNDROME
[French]
LACTIPLANTIBACILLUS PLANTARUM DESTINÉ À ÊTRE UTILISÉ DANS L'AMÉLIORATION DES SYMPTÔMES DU SYNDROME DU CÔLON IRRITABLE
Applicants **
CHR. HANSEN A/S
Inventors
MARTONI, Christopher
Priority Data
22204465.3
28.10.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2057 | |
| EPO | Filing, Examination, Granting | 8801 | |
| Japan | Filing, Examination, Granting | 2229 | |
| South Korea | Filing, Examination, Granting | 2096 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
22,323
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides a method of preventing, reducing, or ameliorating the symptoms of IBS, in a subject in need thereof, with L. plantarum. Further provided is L. plantarum for use in preventing, reducing, or ameliorating the symptoms of IBS. Further provided is a composition comprising L. plantarum for use in preventing, reducing, or ameliorating the symptoms of IBS.[French]
La présente invention concerne un procédé de prévention, de réduction ou d'amélioration des symptômes d'IBS, chez un sujet en ayant besoin, avec L. plantarum. L'invention concerne en outre L. plantarum destiné à être utilisé dans la prévention, la réduction ou l'amélioration des symptômes de l'IBS. L'invention concerne en outre une composition comprenant L. plantarum destinée à être utilisée dans la prévention, la réduction ou l'amélioration des symptômes de l'IBS.